Gerresheimer AG (ETR:GXI)

Germany flag Germany · Delayed Price · Currency is EUR
53.60
+0.20 (0.37%)
Apr 24, 2025, 5:36 PM CET
-47.45%
Market Cap 1.85B
Revenue (ttm) 2.09B
Net Income (ttm) 78.70M
Shares Out 34.54M
EPS (ttm) 2.28
PE Ratio 23.52
Forward PE 10.03
Dividend 1.25 (2.34%)
Ex-Dividend Date Jun 6, 2025
Volume 285,266
Average Volume 317,544
Open 53.60
Previous Close 53.40
Day's Range 51.90 - 54.00
52-Week Range 49.56 - 109.70
Beta 0.95
RSI 30.52
Earnings Date Apr 11, 2025

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufactu... [Read more]

Sector Healthcare
Founded 1864
Employees 12,142
Stock Exchange Deutsche Börse Xetra
Ticker Symbol GXI
Full Company Profile

Financial Performance

In 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.

Financial Statements

News

EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...

9 days ago - Wallstreet:Online

Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Organic Challenges

Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Organic Challenges

12 days ago - GuruFocus

Gerresheimer's first-quarter results hit by low demand in moulded glass

German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe reve...

13 days ago - Reuters

Bormioli Pharma Boosts Gerresheimer's Revenue & Earnings Growth

Gerresheimer's Q1 2025 financial performance paints a picture of strategic growth amidst market challenges, driven by key acquisitions and poised for future expansion. Jetzt den vollständigen Artikel ...

13 days ago - Wallstreet:Online

EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings

EQS-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement Gerresheimer: Bormioli Pharma boosts revenues and earnings 11.04.2025 / 07:00 CET/CEST The issuer is solely responsible for the c...

13 days ago - Wallstreet:Online

KKR drops out of consortium seeking Gerresheimer takeover, Bloomberg News reports

KKR has abandoned a private equity consortium discussing a takeover of Gerresheimer AG , Bloomberg News reported on Thursday, citing people familiar with the matter.

21 days ago - Reuters

Exclusive: KKR, Warburg Pincus group submitted non-binding bid for Gerresheimer, sources say

A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG , which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the matt...

5 weeks ago - Reuters

Warburg Pincus, KKR in Advanced Talks to Buy Gerresheimer

A consortium consisting of Warburg Pincus and KKR & Co. are in talks to acquire Gerresheimer AG, the German maker of packaging for drugs and cosmetics.

6 weeks ago - BNN Bloomberg

Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports

A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , Bloomberg News reported on Wednesday citing people familiar with the matter.

6 weeks ago - Reuters

Gerresheimer AG (GRRMY) Q4 2024 Earnings Call Highlights: Strong Q4 Performance Amid Strategic ...

Gerresheimer AG (GRRMY) Q4 2024 Earnings Call Highlights: Strong Q4 Performance Amid Strategic Shifts

2 months ago - GuruFocus

Gerresheimer AG reports Q4 results

2 months ago - Seeking Alpha

Gerresheimer slashes revenue guidance for 2025 in half

German packaging and medical equipment maker Gerresheimer halved its guidance for 2025 on Wednesday.

2 months ago - Reuters

Gerresheimer Thrives in 2024: Solid Results Amid Market Challenges

In 2024, Gerresheimer showcased resilience with notable financial achievements and promising future prospects, despite market hurdles. Jetzt den vollständigen Artikel lesen

2 months ago - Wallstreet:Online

EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds

EQS-News: Gerresheimer AG / Key word(s): Annual Results Gerresheimer delivers solid results in the financial year 2024 despite market headwinds 26.02.2025 / 07:00 CET/CEST The issuer is solely respons...

2 months ago - Wallstreet:Online

Gerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reports

German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News repo...

2 months ago - Reuters

EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Tender Offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer 07-Feb-2025 / 16:26 CET/CEST Disclosure of an ins...

2 months ago - Wallstreet:Online

German packaging firm Gerresheimer exploring sale, Bloomberg News reports

German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.

2 months ago - Reuters

Gerresheimer: FDA grants Tentative Approval of SQ Innovation's Lasix® ONYU* (FOTO)

Düsseldorf (ots) - - Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerresheimer - Patented device technology for prec...

4 months ago - Wallstreet:Online

EQS-News: Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU*

EQS-News: Gerresheimer AG / Key word(s): Miscellaneous/Regulatory Admission Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU* 16.12.2024 / 09:00 CET/CEST The issuer is solely ...

4 months ago - Wallstreet:Online

Gerresheimer Seals Deal: Acquires Bormioli Pharma's Holding Company

Gerresheimer AG has bolstered its market presence by acquiring Blitz LuxCo Sarl, the parent of Bormioli Pharma Group, enhancing its European production and product offerings in the pharma and biotech ...

4 months ago - Wallstreet:Online

EQS-News: Gerresheimer builds new production capacities for glass syringes at Skopje site

EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer builds new production capacities for glass syringes at Skopje site 02.12.2024 / 13:30 CET/CEST The issuer is solely responsible for the ...

5 months ago - Wallstreet:Online